Annual Drug Patent Expiration for JUBLIA
Jublia is a drug marketed by Bausch and included in one NDA. It is available from a single supplier. There are sixteen patents protecting this drug and one Paragraph IV challenge.
JUBLIA drug price trends.
Drug patent litigation for JUBLIA.
This drug has seventy-seven patent family members in twenty-four countries.
The generic ingredient in JUBLIA is efinaconazole. One registered supplier for this compound. Additional details are available on the efinaconazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the JUBLIA Bausch drug